Literature DB >> 9170158

Molecular basis of congenital hypopigmentary disorders in humans: a review.

R E Boissy1, J J Nordlund.   

Abstract

Many specific gene products are sequentially made and utilized by the melanocyte as it emigrates from its embryonic origin, migrates into specific target sites, synthesizes melanin(s) within a specialized organelle, transfers pigment granules to neighboring cells, and responds to various exogenous cues. A mutation in many of the respective encoding genes can disrupt this process of melanogenesis and can result in hypopigmentary disorders. Following are examples highlighting this scenario. A subset of neural crest derived cells emigrate from the dorsal surface of the neural tube, become committed to the melanoblast lineage, and are targeted along the dorsal lateral pathway. The specific transcription factors PAX3 and MITF (microphthalmia transcription factor) appear to play a regulatory role in early embryonic development of the pigment system and in associated diseases (the Waardenburg syndromes). During the subsequent development and commitment of the melanoblast, concomitant expression of the receptors for fibroblasts growth factor (FGFR2), endothelin-B (EDNRB), and steel factor (cKIT) also appears essential for the continued survival of migrating melanoblasts. Lack or dysfunction of these receptors result in Apert syndrome, Hirschsprung syndrome and piebaldism, respectively. Once the melanocyte resides in its target tissue, a plethora of melanocyte specific enzymes and structural proteins are coordinately expressed to form the melanosome and to convert tyrosine to melanin within it. Mutations in the genes encoding these proteins results in a family of congenital hypopigmentary diseases called oculocutaneous albinism (OCA). The tyrosinase gene family of proteins (tyrosinase, TRP1, and TRP2) regulate the type of eumelanin synthesized and mutations affecting them result in OCA1, OCA3, and slaty (in the murine system), respectively. The P protein, with 12 transmembrane domains localized to the melanosome, has no assigned function as of yet but is responsible for OCA2 when dysfunctional. There are other genetically based syndromes, phenotypically resembling albinism, in which the synthesis of pigmented melanosomes, as well as specialized organelles of other cell types, is compromised. The Hermansky-Pudlak syndrome (HPS) and the Chediak-Higashi syndrome (CHS) are two such disorders. Eventually, the functional melanocyte must be maintained in the tissue throughout life. In some cases it is lost either normally or prematurely. White hair results in the absence of melanocytes repopulating the germinative hair follicle during subsequent anagen stages. Vitiligo, in contrast, results from the destruction and removal of the melanocyte in the epidermis and mucous membranes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170158     DOI: 10.1111/j.1600-0749.1997.tb00461.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  19 in total

Review 1.  Oculocutaneous albinism.

Authors:  S Biswas; I C Lloyd
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 2.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

4.  Update on the regulation of mammalian melanocyte function and skin pigmentation.

Authors:  Taisuke Kondo; Vincent J Hearing
Journal:  Expert Rev Dermatol       Date:  2011-02-01

Review 5.  Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer.

Authors:  Colin R Lindsay; Pavlina Spiliopoulou; Ashita Waterston
Journal:  Ther Adv Med Oncol       Date:  2015-03       Impact factor: 8.168

Review 6.  Cultivation of human keratinocyte stem cells: current and future clinical applications.

Authors:  G Pellegrini; S Bondanza; L Guerra; M De Luca
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

7.  Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance.

Authors:  Ali R Jazirehi; Dylan Arle
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 8.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

9.  [Unilateral sensineural deafness associated with mutations in the PAX3-gene in Waardenburg syndrome type I].

Authors:  M Ptok; S Morlot
Journal:  HNO       Date:  2006-07       Impact factor: 1.284

10.  Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells.

Authors:  Ji Sun Yu; An Keun Kim
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.